In addition, Kaplan–Meier analyses of the COAD‐TCGA cohort indicated that CRC patients with high SLITRK4 expression had remarkably worse overall survival (OS) and disease‐free survival (DFS) than those with low SLITRK4 expression (Figure 1c,d). The gene discussed is SLITRK4; the disease is colorectal carcinoma.